Latest AusBiotech News

AusBiotech and Medicines Australia gather industry leaders to accelerate action this International Women’s Day
New data supports effective delivery of DNA-based vaccines using patch
BioMelbourne Network announces the appointment of new board chair
CSL Seqirus secures Australia-NZ rights to commercialise cholesterol-lowering therapy
Avecho Biotechnology secures ten-year agreement with Sandoz
The Cell and Gene Catalyst mobilises 71 influential leaders to accelerate industry
Arovella receives commitments for $15 million following cancellation of January placement
US FDA accepts application for Telix’s Zircaix and grants priority review
Orthocell submits for Remplir regulatory approval in Thailand
New whitepaper reveals strategies to manage salary trends
Neuren receives rare paediatric disease designation from the US FDA
Syntara’s topical anti-fibrotic drug leads to significant normalisation of skin in established scars
AusBiotech welcomes national prioritisation of R&D to build a stronger Australia
Immunoglobulin Sales Drive Strong First Half For CSL
US University Joins Chimeric’s CHM CDH17 Clinical Trial
Argenica Therapeutics says ARG-007 reduced damage to brain cells in preclinical study
Noxopharm says SOF-SKN passes required in vitro safety tests
AusBiotech and MTPConnect Joint Pre-Budget Submission Lays Pathway to Supercharge Australia’s Life Sciences Sector
AusBiotech Congratulates Members Recognised in Australia Day Honours
Immutep completes patient enrolment for EFTISARC-NEO Phase 2 trial
Neuren partner submits trofinetide marketing application in Europe
Australian company Vaxxas named stage winner of US prize to advance vaccine patches
Industry Growth Program Boosting Aussie Manufacturing
Race Oncology Appoints Opthea Founder To Its Board
Catalyst Impact Report 2024: Mobilising Australia’s Cell and Gene Sector
Immutep and Monash announce first publication detailing how human LAG-3 Binds to MHC Class II
Australian Medtech Manufacturing Alliance adds new steering group members
Call for Member Contributions: April 2025 Edition of Australasian Biotechnology Journal
AusBiotech And BioNSW Sign MOU To Deepen Collaboration
AusBiotech and BioMelbourne Network welcome the Victorian Government’s Economic Growth Statement
FivepHusion secures ethics approval of a Phase 1b deflexifol clinical trial
Recce receives approval from Indonesia’s regulator for registrational Phase 3 clinical trial
AusBiotech Celebrates ESIF Winners
Orthocell says it has achieved all endpoints in pivotal of nerve repair product
AusBiotech Welcomes Government’s Review Of R&D
AusBiotech Welcomes New Board Director
National Biotech and Medtech Development and Commercialisation Summit: Outcomes and Communique
Title: National Biotech and Medtech Development and Commercialisation Summit: Outcomes and Communique
AusBiotech welcomes the announcement of the HTA Implementation Advisory Group
New digital project to reveal medical research career opportunities
Race Oncology says it has discovered multiple novel FTO inhibitor candidates
Neurizon Therapeutics says candidate reduces aggregation of key ALS disease target
AdAlta announces appointment of two new non-executive directors
AusBiotech and MTPConnect Bring Together Australia’s Life Sciences Sector for a First-Ever National Summit
Amplia enters into preclinical collaboration with Korean drug screening company
AusBiotech Announces Inaugural Depaz Oration
AusBiotech And MTPConnect Launch Joint Discussion Paper On Critical Life Science Growth Issues Ahead Of National Summit
Recce says patient dosing in Phase 2 clinical trial advances to final stages